Astria Therapeutics
Joanne T. Beck, Ph.D. has served as a member of our Board of Directors since February 2019. Dr. Beck is currently the Chief Operating Officer at Boston Pharmaceuticals. From 2016 to 2019, Dr. Beck was the Executive Vice President of Global Pharmaceutical Development and Operations and a member of the Executive Committee at Celgene. From 2012 to 2016, Dr. Beck was Senior Vice President of Pharmaceutical Development at Shire. Prior to Shire, she held positions of increasing responsibility in Abbott’s Global Pharmaceutical Operations and was the site head of Abbott Vascular Instruments GmbH. Prior to Abbott, Dr. Beck held positions in Process Development at both Genentech and Amgen. Dr. Beck serves on the board of directors for Orchard Therapeutics. She holds a BA in Chemistry from Lewis and Clark College, a Ph.D. in Biochemistry and Molecular Biology from Oregon Health and Science University and completed a postdoctoral fellowship in the department of Pharmaceutical Chemistry at the University of California, San Francisco.
This person is not in the org chart
This person is not in any offices
Astria Therapeutics
2 followers
With patients as their guiding stars, Astria Therapeutics’ dedicated and passionate team is devoted to bringing life-changing therapies to patients and families impacted by HAE and rare and niche allergic and immunological diseases.